To meet the increased performance needs of intensified bioprocesses, being flexible and scalable across sizes is the key to future-proof your process. Learn now how the enhanced performance can support diverse operational strategies.
- Amandine Biehlerhttps://emergingbiotalk.com/author/amandine-biehler/
- Amandine Biehlerhttps://emergingbiotalk.com/author/amandine-biehler/
- Amandine Biehlerhttps://emergingbiotalk.com/author/amandine-biehler/
- Amandine Biehlerhttps://emergingbiotalk.com/author/amandine-biehler/
Related Posts
Emerging Biotech · Gene Therapy
Starting your journey into manufacturing – choosing a cell line development provider
One of the biggest decisions which any company developing biological medicines makes is to move forward to the manufacture of their product. …
by Dr. Jonathan H. Dempsey
Vaccines
Covid-19 Impact on Bioprocessing: PART 1 Accelerating Trends
The views and opinions expressed in this blog / article are those of the authors and do not…
by Eric Langer, Ronald Rader and Kamna Jhamb
Vaccines
Covid-19 Impact on Bioprocessing: PART 2 Fears to Be Addressed due to Covid-19
The views and opinions expressed in this blog / article are those of the authors and do not…
by Ronald Rader, Kamna Jhamb and Eric Langer
Vaccines
Covid-19 Impact on Bioprocessing: PART 3 Long-term Changes Resulting from the Pandemic
The views and opinions expressed in this blog / article are those of the authors and do not…
